Navigation Links
Cell Therapeutics Updates Shareholders on Trading
Date:2/11/2009

e trading in Italy. The Company believes that it is currently in compliance with all undertakings for filing and reporting obligations in Italy as agreed with the Borsa Italiana and CONSOB when the shares were accepted for listing in Italy.

The Company is diligently working with the Borsa Italiana, CONSOB and the NASDAQ Stock Market to have one or both markets resume trading in the Company's common stock.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.CellTherapeutics.com.

This press release contains forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect future results. The risks and uncertainties include that the Company may not be able satisfy the Italian regulatory authorities requests for information; the Borsa Italiana may choose not to lift the trading halt in Italy; the Company's current extension of time to comply with the NASDAQ listing requirements may not be extended by the NASDAQ Qualification Panel and the Company may be delisted by NASDAQ; the Company's operating expenses continue to exceed its net revenues and the Company will continue to need to raise capital to fund its operating expenses; as well as other risks listed or described from time to time in the Company's most recent filings with the SEC on Forms 10-K, 8-K and 10-Q. Except as required by law, the Company does not intend to update any of the statements in this press release upon further developments.

     Media Contact:
     Dan Eramian
     T: 206.272.4343
     C: 206.854.1200
     E: media@ctiseattle.com
   
'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results
2. Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
3. Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2009 Financial Results on Wednesday, February 11th, at 4:30 P.M. EST
4. Transition Therapeutics Announces Completion of Patient Enrolment of Phase 2 Study of TT-223 in Type 2 Diabetes Patients
5. Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference
6. Nile Therapeutics to Present at the 27th Annual J.P. Morgan Healthcare Conference
7. Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
8. AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics
9. Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
10. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
11. Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... (PRWEB) April 18, 2015 In the ... a couple of changes. , "We had to run ... make needed changes," said Jennifer Ramirez, the PR Director. ... happy to say that we are back on track ... in the process of changing phone systems which has ...
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch as part ... latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... In a turbulent world, people may find themselves in dangerous ... their first move, but some situations can be avoided if ...
(Date:4/17/2015)... John Evans, a Gardant affordable assisted living ... 2 p.m. to 3 p.m. on April 24. , ... in Pekin, Illinois, serves older adults of all incomes, ... maintain their independence. , Becky Baker will entertain guests ... served during the luau. , For more information, call ...
(Date:4/17/2015)... Alcohol and Violence , The National Council on ... driving has been the focus of much public and ... between alcohol and crime received less public attention. , ... assault, and their relationship to alcohol have been clearly ... in America were drinking alcohol at the time of ...
(Date:4/17/2015)... D.C. (PRWEB) April 17, 2015 In ... issued the following statement: “On Wednesday April 15th, the ... and adopted a resolution recognizing the Armenian Genocide, “paying ... memory of the one-and-a-half million innocent Armenian victims who ... Christians (IDC) extols the EU for this timely and ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Temporary Number Available 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3
... , WEDNESDAY, April 25 (HealthDay News) -- Air ... the past decade, according to a new report from the ... morning smog, is the cleanest it,s been in 13 years, ... been ranked as the cleanest city in the nation. ...
... By Jenifer Goodwin HealthDay Reporter ... experimental drug reduced two signature characteristics of autism ... in laboratory mice, new research finds. The ... throughout the brain that,s involved with activating neurons, ...
... of dandruff the embarrassing nuisance that, by some accounts, ... much-needed new treatment for the condition,s flaking and itching. The ... Journal of Medicinal Chemistry . Claudiu T. Supuran and ... skin cells from the scalp. In people without dandruff, it ...
... Mich.Brain scans of a small group of people can predict ... by researchers from the University of Michigan, the University of ... The findings are relevant to political advertising, commercial market research ... imaging from a diagnostic to a predictive tool. As ...
... stomachs of pigs could be a long-sought, abundant source of ... supplement baby formula and for use in personal hygiene and ... infections. Their study appears in ACS, journal Biomacromolecules . ... that mucus, which coats the inside of the nose, mouth ...
... By Serena Gordon HealthDay Reporter , TUESDAY, ... preventive medication for debilitating migraine headaches, but a new review ... or chronic daily headaches. And, even then, the effect appears ... found that Botox (botulinum toxin A) was no help for ...
Cached Medicine News:Health News:Air Quality Improving in Many U.S. Cities: Report 2Health News:Air Quality Improving in Many U.S. Cities: Report 3Health News:Experimental Drug Eases Autistic Behaviors in Mice 2Health News:Experimental Drug Eases Autistic Behaviors in Mice 3Health News:Experimental Drug Eases Autistic Behaviors in Mice 4Health News:Small 'neural focus groups' predict anti-smoking ad success 2Health News:Small 'neural focus groups' predict anti-smoking ad success 3Health News:Botox Offers Little Relief for Migraine, Study Finds 2Health News:Botox Offers Little Relief for Migraine, Study Finds 3
(Date:4/17/2015)... , April 17, 2015  Regulatory leaders in ... released bipartisan discussion draft called "21 st Century ... planned to be taken up by Congress soon and ... and medical device products are developed and marketed in ... reason, many companies have begun to consider how the ...
(Date:4/17/2015)... 17, 2015  AbbVie Inc. ("AbbVie") (NYSE / CHX / ... extended the expiration of its exchange offer to acquire all ... to 5 p.m., New York City ... 17, 2015, AbbVie also voluntarily withdrew its initial Notification and ... to provide the FTC with additional time to review the ...
(Date:4/17/2015)... April 17, 2015 Nonin Medical, a global ... and Chief Operating Officer Steve Bucholz will ... is expanding his role as Chief Executive Officer. In ... Chief Technology Officer. Operations will transition to David ... Bucholz has been instrumental to Nonin Medical,s growth," ...
Breaking Medicine Technology:21st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2
... Study into Lethal ,Super, Strains of C.difficileCHICAGO, Jan. 28 ... announced that scientists at The University of Nottingham are ... code of one of the most lethal strains of ... gene knock-out technology developed in Nottingham to study the ...
... Medical Solutions, Inc. (OTC Bulletin Board: IMSU), a medical ... has joined the Company,s Board of Directors. Mr. ... Inc., a Montreal-based financial consultancy group that provides corporate ... also the President and CEO of Orex Exploration Inc., ...
Cached Medicine Technology:British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 3Impact Medical Solutions Announces Appointment of New Director and Corporate Update 2Impact Medical Solutions Announces Appointment of New Director and Corporate Update 3
Galaxy IVUS Imaging System simplifies the process of intracardiac echo while delivering accurate, real-time diagnostic information in less time with less work. (Ultra ICE catheter compatible)...
The Duett Pro is simple, precise and efficient. Duett Pro sleeve hub is lightweight and ergonomic. A 'quick connect' feature provides a secure connection of the sleeve hub to the base during catheter...
... VasoSeal VHD was ... rapidly stop bleeding after ... and radiology procedures. It ... sealing device approved for ...
... was the first device ... after diagnostic and interventional ... It is a collagen-based ... for immediate sheath removal ...
Medicine Products: